SpringLoc

Personalized Breast Conservation Surgery System

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem Founded 2020
LinkedIn
Total raised
Stage
Pre-Funding
Founded
2020
Headcount
1
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

SpringLoc AR is poised to revolutionize Breast-Conserving Surgeries, specifically Lumpectomies, through a future-oriented approach centered on Augmented Reality (AR) technology. The company's strategic vision involves the development and implementation of proprietary smart breast markers, serving as a distinctive solution in breast surgery.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is SpringLoc's primary focus in the medical field?
SpringLoc is focused on revolutionizing Breast-Conserving Surgeries, specifically Lumpectomies, through Augmented Reality (AR) technology.
What specific technology does SpringLoc utilize in its surgical approach?
SpringLoc utilizes Augmented Reality (AR) technology and proprietary smart breast markers for breast surgery.
When was SpringLoc founded?
SpringLoc was founded in December 2020.
What is SpringLoc's current funding stage?
SpringLoc is currently in the Pre-Funding stage.
How many employees does SpringLoc currently have?
SpringLoc has 1-10 employees.
Which geographic markets does SpringLoc target?
SpringLoc targets the North America and Europe geographic markets.
What is the primary sector classification for SpringLoc?
SpringLoc's primary sector classification is Health Tech & Life Sciences.
Does SpringLoc hold any patents?
Yes, SpringLoc holds 1 patent.
Who is a founder of SpringLoc?
David Nitsan is a founder of SpringLoc.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDigital Healthcare
Technologies
Simulation & ImagingAugmented Reality
Target customers
Healthcare & Life SciencesHealthcareMedical Devices Industry
Business model
B2C

Highlights

1 PatentsVerified